Chris Bostick

Chris Bostick is a Partner at OCV and is passionate about technologies enabling precision medicine. Prior to OCV Dr. Bostick obtained his Ph.D. in Pharmaceutical and Pharmacological Sciences from West Virginia University researching protein immobilization for studying electron transfer and protein-protein interactions in Cytochrome P450s. For his postdoctoral work, he studied precision medicine-based approaches for genetic epilepsies at the Institute for Genomic Medicine at Columbia University. Dr. Bostick holds a B.S. in Biology from Cornell University and a Ph.D. in Pharmacological and Pharmaceutical Sciences from West Virginia University.

Chris serves as a Board Observer for Ossio.